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OBJECTIVES We sought to examine saphenous vein graft (SVG) lesions that fail within the first year after
operation.
BACKGROUND Saphenous vein grafts remain patent for approximately 10 years; however, up to 15% to 20%
of SVGs become occluded within the first year.
METHODS We studied 100 patients who underwent percutaneous coronary intervention (PCI) for early
(1 year post-implantation) SVG failure lesions and compared them with a diabetes- and
hypercholesterolemia-matched cohort of late SVG failures (1 year). Coronary angiography
and intravascular ultrasound images were analyzed.
RESULTS The majority of patients in both groups were males who presented with unstable angina; 36%
were diabetic. Graft ages were 6.0 2.9 months and 105.4 50.8 months, respectively. The
early SVG failure lesion location was more often ostial or proximal (62% vs. 42%,
respectively). Early SVG failures were angiographically smaller than late failures (reference:
2.47  0.86 mm vs. 3.26  0.83 mm, p  0.001) but had similar lesion lengths. Intra-
vascular ultrasound showed that early failure lesions had smaller proximal and distal
reference lumen areas (7.3  6.8 mm2 vs. 10.6  3.8 mm2, p  0.026) and greater
reference plaque burden than late failures (52.3% vs. 36.1%, p  0.001). After PCI,
20.6% of early and 30.6% of late failure lesions had creatine kinase-myocardial band
(CK-MB) greater than twice normal.
CONCLUSIONS Early SVG failure is mostly proximal or ostial, lesions appear focal, and early SVGs appear
smaller than late SVGs. Intravascular ultrasound shows significant reference segment plaque
burden, suggesting more severe, diffuse SVG disease. (J Am Coll Cardiol 2004;44:53–6)
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toronary artery bypass graft surgery utilizing saphenous
ein grafts (SVGs) is a proven technique for the treatment
f intractable angina and, in select populations, improves
ong-term prognosis (1,2). The SVG conduits last 10
ears (3–6). However, up to 15% fail within the first year,
sually resulting in percutaneous coronary intervention
PCI) (7). The etiology of early (within 1 year) graft failure
s poorly understood. To better understand this issue, we
ndertook a retrospective clinical, angiographic, and intra-
ascular ultrasound (IVUS) comparison between patients
ho presented with early versus late (1 year) graft failure
ho were then treated with PCI.
ETHODS
retrospective analysis of the institution’s catheterization
atabase was performed to identify all patients who under-
ent PCI on one or more SVG lesions within one year of
VG implantation. Between January 1, 1991, and January 1,
001, 3,775 SVG lesions were treated, of which 100
atients (121 lesions) had treatment within one year of graft
mplantation and had pre-interventional IVUS. Early fail-
From the *Cardiovascular Research Institute, Washington Hospital Center,
ashington, DC; and †Cardiovascular Research Foundation, New York, New York.
Manuscript received March 10, 2003; revised manuscript received March 10, 2004,mccepted March 16, 2004.re patients were matched with late SVG failure patients on
1:2 ratio based on diabetes and hypercholesterolemia
tatus. Restenotic SVG lesions were excluded. The revas-
ularization method was performed at the discretion of the
perator. Baseline demographics and in-hospital complica-
ions were confirmed by independent hospital chart review.
ngiographic analysis. Angiographic analysis was per-
ormed using a computer-assisted, automated edge-
etection algorithm (CAAS II, Pie Medical Imaging BV,
aastricht, The Netherlands) independent of clinical and
VUS information. Using the outer diameter of the
ontrast-filled catheter as the calibration standard, the
eference diameter and minimum lumen diameter (MLD)
ere measured before and after intervention from multiple
rojections. The results from the “worst” view were re-
orded, and percent diameter stenosis was calculated. Le-
ion lengths were measured in the view with the least
mount of foreshortening. Degenerated SVGs were those
ith ectasia or lumen irregularity comprising 50% of the
VG shaft length. Ectasia was a lumen 20% larger than
he reference segment. Ostial segments were defined 5
m from the proximal anastomosis.
ntravascular ultrasound imaging and analysis. Imaging
ith IVUS was performed immediately before PCI, after
he administration of intracoronary nitroglycerin, using a
otorized pullback and a commercially available scanner
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Early SVG Failure July 7, 2004:53–6SciMed/Boston Scientific, Maple Grove, Minnesota). Af-
er the imaging catheter was advanced at least 10 mm
eyond the lesion edge into the distal graft, the transducer
as withdrawn at 0.5 mm/s to the aorto-ostial junction.
Lesion site and reference segment SVG wall cross-
ectional area (CSA) and lumen CSA were obtained via
omputerized planimetry (Tape Measure, Indec, Mountain
iew, California), according to published guidelines (8).
he SVG plaque CSA was defined as SVG wall CSA
inus lumen CSA. Plaque burden was calculated as SVG
laque CSA divided by SVG wall CSA. Remodeling was
alculated as lesion divided by mean reference SVG wall
SA.
tatistical analysis. Statistical analysis was performed us-
ng the SAS statistical package, version 8.0 (SAS Institute,
nc., Cary, North Carolina). Continuous variables are pre-
ented as the mean value  SD and compared using the
tudent t test. Discrete variables are presented as percent-
ges and relative frequencies and compared using the
hi-square statistic or Fisher exact test.
ESULTS
atient characteristics. The clinical characteristics of the
arly failure (121 lesions) and late failure patients (289
esions) are displayed in Table 1. The majority were men
70.0% early and 76.5% late, p  0.22) with a similar age
64.8  9.8 early vs. 66.5  9.6 years, p  0.17). Most had
nstable angina (81.8% early and 73.1% late). The mean
VG age was 6.0 2.9 months in the early group compared
ith 105.4  50.8 months in the late group.
rocedural and angiographic characteristics. Percuta-
eous interventions differed in the early versus late groups,
ncluding stents (50.9% vs. 68.9%, p 0.001), balloon alone
25.9% vs. 16.4%, p  0.030), and laser or atherectomy
42.2% vs. 28.2%, p  0.007) (Table 2). Early and late
ailure lesions had a high frequency of creatine kinase-
yocardial band (CK-MB) greater than twice normal
20.6% and 30.6%, respectively).
Quantitative coronary angiography (QCA) analysis
howed that vein grafts that failed early had a smaller
re-PCI reference diameter (2.47  0.86 mm vs. 3.26 
.83 mm, p  0.001), smaller pre-PCI MLD (0.80  0.64
s. 1.08  0.64, p  0.001), and greater pre-diameter
tenosis (71.6  19.0% vs. 66.7  17.7%, p  0.017). Early
Abbreviations and Acronyms
CK-MB  creatine kinase-myocardial band
CSA  cross-sectional area
IVUS  intravascular ultrasound
MLD  minimum lumen diameter
PCI  percutaneous coronary intervention
QCA  quantitative coronary angiography
SVG  saphenous vein graft
TIMI  Thrombolysis In Myocardial Infarctionraft failure was associated with lower pre-Thrombolysis In Ayocardial Infarction (TIMI) flow rates (13.4% vs. 3.6%
ad TIMI flow grade 0 or 1, p  0.001). There was no
ifference between the early and late failure lesion lengths or
resence of thrombus (11.6% early vs. 12.6% late, p  0.8).
rafts that failed late were more likely to be degenerated
43.1% vs. 29.5%, p  0.015). Post-PCI QCA analysis
howed that grafts that failed early had a smaller MLD
2.33  0.96 vs. 2.91  0.85, p  0.001) and greater
tenosis (16.3  24.0% vs. 11.6  18.1%, p  0.037).
ntravascular ultrasound findings. Pre-intervention quanti-
ative and qualitative results are shown in Table 3. The early
ailure reference segments had a greater plaque burden
distal: 52.3  0.2% vs. 33.6  0.1%, p  0.001; proximal:
4.4  0.2% vs. 38.3  0.1%, p  0.002; lesion: 81.7 
.1% vs. 74.4  0.1%, p  0.009). There was also a
ignificant difference between the plaque morphology in the
arly versus late failure groups. Vein grafts that failed early
ere more likely to be fibrotic (26.7% vs. 3.5%, p  0.026),
hereas grafts that failed late were more likely to be calcific
17.9% vs. 0%, p  0.021).
ISCUSSION
ur study found that grafts that fail early are relatively
mall, less likely to be degenerated, mostly located in the
stial or proximal third portion of the graft, and had an
ncreased frequency of TIMI flow grade 0/1. The diffuse
isease (mean reference segment plaque burden 50%) of
arly failures was reflected in the high rate of procedural
K-MB release.
Previous studies have not focused on the angiographic
ndings in early graft failure. Savage et al. (9) performed
ngiographic analysis on 215 SVG lesions before PCI. The
ean graft age in their study was 9.7 years, and 7%
ontained a definite thrombus. The majority of lesions were
ocated in the proximal and mid portions of the grafts.
able 1. Baseline Patient Demographics
Early SVG
Failure
(n  100)
Late SVG
Failure
(n  200) p Value
ge (yrs) 64.8  9.8 66.5  9.6 0.172
ale (%) 70.0 76.5 0.224
nstable angina (%) 81.8 73.1 0.097
iabetes mellitus (%) 36.0 36.0 1.0
Insulin-dependent (%) 14.0 14.0 1.0
ypercholesterolemia (%) 70.0 70.0 1.0
ypertension (%) 63.0 71.5 0.135
eft ventricular ejection
fraction (%)
39  13 41  12 0.279
revious myocardial
infarction (%)
60.0 63.2 0.597
amily history (%) 62.3 54.8 0.338
istory of smoking (%) 44.0 43.5 0.934
urrent smoker (%) 18.0 19.0 0.834
raft age (months) 6.0  2.9 105.4  50.8 0.001
ata are presented as percentages or mean  SD.
SVG  saphenous vein graft.hmed et al. (10) studied 340 lesions with a mean graft age
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July 7, 2004:53–6 Early SVG Failuref eight years, with similar findings. They reported that
.6% of the lesions contained a thrombus and 36.3% were
egenerated. Finally, Le May et al. (11) studied grafts that
ailed after an average of 9.9 years. The majority of lesions
75%) were found in the body of the graft, with thrombus in
1%.
This study is in concordance with these previous studies
nd found that early failure SVGs were angiographically
maller. Intravascular ultrasound analysis suggested that
hese “angiographically small” early failure grafts were actu-
lly diffusely diseased vessels without positive remodeling,
esulting in small lumens. The lesion site remodeling
ndex measured 0.97  0.23 in the early failure group (no
emodeling). The existence of remodeling within vein grafts
s controversial. Nishioka et al. (12) examined 43 SVGs
ith a mean age of 11  4 years. They found that SVGs do
Table 2. Lesion Location and Procedural Infor
Ear
Lesion location
Ostial (%)
Proximal (%)
Mid (%)
Distal (%)
Distal anastomotic (%)
Procedures
Balloon only (%)
Stent only (with or without pre- or
post-dilation) (%)
Excimer laser (%)
With or without adjunct balloon (%)
With adjunct stent (%)
Atherectomy (%)
With or without adjunct balloon (%)
With adjunct stent (%)
SVG  saphenous vein graft.
Table 3. Pre-intervention Quantitative and Qu
Early SVG F
(n  30
Proximal reference
SVG wall CSA (mm2) 14.05  9
Lumen CSA (mm2) 6.80  7
SVG plaque CSA (mm2) 7.25  3
Lesion
SVG wall CSA (mm2) 13.73  7
Lumen CSA (mm2) 2.15  1
SVG plaque CSA (mm2) 11.56  6
Remodeling index 0.97  0
Plaque morphology
Soft lesions (%) 40.0
Fibrotic lesions (%) 26.7
Mixed lesions (%) 33.3
Calcific lesions (%) 0
Distal reference
SVG wall CSA (mm2) 14.21  7
Lumen CSA (mm2) 6.79  5
SVG plaque CSA (mm2) 7.42  4
Data are presented as the mean value  SD or percentage.
CSA  cross-sectional area; SVG  saphenous vein graft.ot undergo compensatory enlargement and suggested it as
potential factor affecting progression of SVG stenoses.
owever, other investigations reported significant positive
emodeling in SVG lesions (13–15). These latter studies
ndicated that diseased SVGs can undergo remodeling
esponses that prevent lumen compromise, similar to native
oronary arteries. Conversely, as in the current report, grafts
hat become diseased but that do not remodel will develop
mall reference lumen areas; this appears to be especially
rue for early SVG failures.
tudy limitations. There are several limitations to this
tudy. First, this study is a retrospective analysis that is
ubject to its inherent limitations. Second, there may have
een a selection bias in that only patients undergoing
re-intervention IVUS were studied. Third, a common
resentation of early SVG failure is thrombotic occlusion,
on
G Failure
121)
Late SVG Failure
(n  289) p Value
7.5 17.5 0.001
4.2 24.5 0.947
2.5 29.4 0.001
3.3 19.6 0.133
2.5 10.0 0.481
5.9 16.4 0.030
3.6 56.1 0.001
5.0 15.7 0.030
3.8 8.9 0.148
1.2 6.8 0.142
7.2 12.5 0.214
1.2 6.4 0.107
6.0 6.1 0.989
ive Intravascular Ultrasound Characteristics
e Late SVG Failure
(n  28) p Value
18.78  7.16 0.085
11.45  4.49 0.024
7.32  3.69 0.948
16.78  4.81 0.071
4.96  3.52 0.001
12.51  4.20 0.517
1.07  0.21 0.091
0.001
71.4 0.0162
3.5 0.0261
7.1 0.0139
17.9 0.0214
14.62  6.67 0.841
9.89  4.85 0.028
4.86  2.70 0.012mati
ly SV
(n 
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Early SVG Failure July 7, 2004:53–6nd patients with thrombotic occlusion usually do not
ndergo PCI. As such, the current study is a report of early
VG failure lesions undergoing PCI.
onclusions. Early SVG failure lesions represent an ag-
ressive, diffuse disease process throughout the graft.
eprint requests and correspondence: Dr. Neil J. Weissman,
ardiovascular Research Institute, 110 Irving Street NW,
uite 4B-1, Washington, DC 20010. E-mail: Neil.J.Weissman@
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